AU4100193A - Use of udpg as cancer therapy rescue agent - Google Patents

Use of udpg as cancer therapy rescue agent

Info

Publication number
AU4100193A
AU4100193A AU41001/93A AU4100193A AU4100193A AU 4100193 A AU4100193 A AU 4100193A AU 41001/93 A AU41001/93 A AU 41001/93A AU 4100193 A AU4100193 A AU 4100193A AU 4100193 A AU4100193 A AU 4100193A
Authority
AU
Australia
Prior art keywords
udpg
cancer therapy
rescue agent
therapy rescue
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41001/93A
Inventor
Robert L. Stolfi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics SpA
Original Assignee
Boehringer Mannheim Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Italia SpA filed Critical Boehringer Mannheim Italia SpA
Publication of AU4100193A publication Critical patent/AU4100193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU41001/93A 1991-12-16 1991-12-16 Use of udpg as cancer therapy rescue agent Abandoned AU4100193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1991/007613 WO1993013779A2 (en) 1991-12-16 1991-12-16 Use of udpg as cancer therapy rescue agent

Publications (1)

Publication Number Publication Date
AU4100193A true AU4100193A (en) 1993-08-03

Family

ID=22225879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41001/93A Abandoned AU4100193A (en) 1991-12-16 1991-12-16 Use of udpg as cancer therapy rescue agent

Country Status (4)

Country Link
EP (1) EP0617625A1 (en)
JP (1) JPH07501810A (en)
AU (1) AU4100193A (en)
WO (1) WO1993013779A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR951101A0 (en) * 2001-12-13 2002-01-24 Centre For Molecular Biology And Medicine Method of treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205586B1 (en) * 1984-12-20 1994-06-22 Memorial Hospital for Cancer and Allied Diseases Composition comprising udpg and other anti-tumor drugs for treatment of tumors

Also Published As

Publication number Publication date
JPH07501810A (en) 1995-02-23
WO1993013779A3 (en) 1993-08-19
EP0617625A1 (en) 1994-10-05
WO1993013779A2 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
AU589371B2 (en) Purine derivatives and use as therapeutic agent
AU4873193A (en) Use of substituted benzimidazoles
GB9518115D0 (en) Triazole derivatives and their use as therapeutic agents
AU6721598A (en) Dioxino derivatives and their use as therapeutic agents
AU7272196A (en) Use of hyaluronan in gene therapy
AU2804592A (en) Compositions and methods for therapy and prevention of cancer, aids, and anemia
AU5590696A (en) Use of quinones in the treatment of cancer or AIDS
AU588862B2 (en) Human tumor therapy
IL101410A0 (en) Formulation for the treatment of cancer
GB9219425D0 (en) Therapeutic agent and its use
GB2280036B (en) Therapy tomograph
AU2265695A (en) The use of sertraline to treat cancer patients
AU4100193A (en) Use of udpg as cancer therapy rescue agent
GB9308166D0 (en) Cancer therapy
GB9106170D0 (en) New compounds for use in the treatment of cancer
ZA943342B (en) The use of compositions for combating tumour diseases
AU5371694A (en) Use of the tarchonanthus camphoratus
AU7753887A (en) Pyridone-pyridyl-imidazolyl and triazolyl compounds and their use as cardiotonic agents
HU905325D0 (en) The use of iodine-propargyl-acid-esthers of alpha-amino-derivatives as antimicrobial agent
AU4825993A (en) New compounds for use in the treatment of cancer
AU8508991A (en) Use of 4-hydroxyphenyl-thioethers for stimulating superoxide generation
AU5165993A (en) Pp14-based therapy
AU648084B2 (en) Agent for therapy
AU1718292A (en) An inhibiting agent against the proliferation of malignant tumor cells of animals including human beings and its manufacture
AU5453490A (en) Therapeutic uses of cyanocobalamin